Ultragenyx Pharma (RARE) – Guidance
-
Ultragenyx Pharma (RARE) Reports Preliminary 2023 Revenue, 2024 Guidance
-
Mereo BioPharma (MREO) Reports on Recent Program Developments and Provides Financial Update
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RARE Stock Lookup